PhaseBio Pharmaceuticals Inc (PHAS) has 21 open-market insider trades by 13 insiders since 2018. The most active filer is Clay Thorp, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Scott D. Sandell | 10% Owner | — | 1 | $9.0M | 2018-10-22 |
| Astrazeneca PLC | 10% Owner | — | 1 | $3.0M | 2018-10-22 |
| Clay Thorp | Dir10% Owner | — | 5 | $1.6M | 2023-05-19 |
| Kenneth B. Lee Jr. | 10% Owner | — | 1 | $1.5M | 2018-10-22 |
| NEW Enterprise Associates 13 L.P. | 10% Owner | — | 1 | $535K | 2022-10-25 |
| Linda Tufts | Dir | — | 1 | $100K | 2018-10-22 |
| Edmund Harrigan | Dir | — | 1 | $25K | 2023-05-19 |
| Glen Burkhardt | SVP of Human Resources | — | 2 | $25K | 2022-05-23 |
| John P. Sharp | CFO | — | 1 | $19K | 2022-05-20 |
| Jonathan P. Mow | CEO | — | 3 | $18K | 2022-05-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| NEW Enterprise Associates 13 L.P. | 10% Owner | Sell | $535K | 2022-10-25 |
| Glen Burkhardt | SVP of Human Resources | Sell | $9K | 2022-05-23 |
| Glen Burkhardt | VP & Human Resources | Sell | $14K | 2021-11-19 |
| Nancy J. Hutson | Director | Buy | $9K | 2021-08-18 |
| Clay Thorp | Director | Buy | $30K | 2021-08-18 |
| Glen Burkhardt | VP & Human Resources | Sell | $13K |
Companies that share insiders with PHAS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-05-20 |
| Edmund Harrigan | Director | Buy | $25K | 2020-12-03 |
| Glen Burkhardt | VP & Human Resources | Sell | $12K | 2020-11-23 |
| Clay Thorp | Director | Buy | $18K | 2020-11-23 |
| Clay Thorp | Director & 10% Owner | Sell | $41K | 2019-07-01 |
| Clay Thorp | Director & 10% | Sell | $6K | 2019-06-18 |
| Nancy J. Hutson | Director | Buy | $4K | 2018-12-17 |
| Jonathan P. Mow | CEO | Buy | $4K | 2018-12-13 |
| David James Ballance | VP & Research and Sci. Affairs | Buy | $4K | 2018-12-13 |
| Michael York | VP & Corporate Development | Buy | $6K | 2018-12-11 |